The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: John Wilkinson

Post-Vacation Brain Dump: Canadian Developments

Here’s a bit of Canadiana to start off the catching up:

Bookmark and Share

BIO 2009: Ontario Premier’s Breakfast

BIO 2009The speeches (s-peach-es?) just finished this morning at the Ontario Premier’s breakfast.

Minister of Research and Innovation John Wilkinson announced that Ontario has recently completed 2 new BIP investments:

Ontario’s Premier — Dalton McGuinty, winner of BIO’s second annual International Leadership Award — spoke next, highlighting the Ontario Innovation Agenda, including BIP, business tax reductions and recent funding in the Emerging Technologies Fund and the new $100 million for genomics research.

Dr. Nagy also spoke, emphasizing the $100 million of new funding and the value of a peer group of 95 P.I.’s in Ontario working on stem cells and regenerative medicine. Current work focuses on cell type switching without regression to pluripotency.

On to the omelet…

P.S.  First time here at the Cross-Border Biotech Blog?  Welcome! Check out who we are, check out our Trends in 2009 series, or hit the search and navigation tools on your right and see if you see anything interesting.

Bookmark and Share

It’s a Bird! It’s a Plane! It’s Super Provincial Genomics Funding!!

You may remember Genome Canada’s reaction to the 2009 Canadian Federal budget.  Here’s one bit from ScienceInsider at the time:

Researchers funded by Genome Canada … are reacting with shock to news that the Canadian government is withdrawing funding from the 9-year-old organization.

Not true! Cried the Canadian government.

Well, this week Genome Canada’s Board decided  (unanimously) to withdraw funding from the International Regulome Consortium project.  Here’s the reaction from IRC:

Michael Rudnicki, the senior scientist and chair of the International Regulome Consortium, said he is devastated by the news.  He said Martin Godbout, president and CEO of Genome Canada, phoned him this week to say that the agency had to terminate its support because of the budget.

Not true!  Cried Genome Canada.  Well, there’s some support for that, with Godbout citing “significant scientific and management issues;” but more importantly, the recent Ontario Budget included $100 million in the Ontario Research Fund to support “genomics and gene-related research,” so I don’t think genomics research in Ontario is short the money right now.

In fact, according to Ontario Minister of Research and Innovation John Wilkinson’s comments at a BIO2009 preparation meeting last week, that $100 million is targeted to rebut any suggestion of a weakening of support for genomics research in Ontari0.

And, right at the other end of the Ontario-Quebec Corridor, a $5 million donation plus a $6.6 million construction investment, plus recruitment of internationally renowned scientists, has added up to over $80 million in funding attracted from various sources to advance pharmacogenomics and personalized medicine research at the new Centre de pharmacogénomique Beaulieu-Saucier de l’Université de Montréal (Beaulieu-Saucier Centre for Pharmacogenomics at the University of Montréal).

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 131 other followers